All In MedTech

Device Trial Radar · NCT04558944

The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Post Burn Scars

Clinical Use of the Extracorporeal Shock Wave Therapy in the Treatment of Pathological Post Burn Scars

Last checked: Nov 19, 2026Latest source record: Oct 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jan 1, 2017

Primary completion

Feb 15, 2019

Study completion Feb 15, 2019

Sponsor

Lead sponsor
Hospital Universitari Vall d'Hebron Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 22, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, randomized, controlled study. The patients were divided into two groups with twenty patients per group. The control group received the standard treatment for postburn scars. The treatment group received the standard treatment and treatment of postburn scars with Extracorporeal Shock Wave Therapy 512 impulses of 0.15mJ/mm 2 in each session, twice per week for 4 weeks. The investigators assessed the appearance of scar with the Vancouver Scar Scale (VSS), pruritus and pain with Visual Analog Scale (VAS) before the start of the treatment and at 2 weeks and 5 months after the treatment.

Conditions

  • Cicatrix, Hypertrophic

Interventions

  • Extracorporal Shock Wave TherapyDevice

    Acoustic high amplitude waves with Energy Flux Density of 0.15mJ/mm 2 and 512 pulses per session. A total of two sessions per week during a 4-week period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Scar appearanceTime frame: 6 months from inclusion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jorge Aguilera Sáez

    Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.